Myself is not a trained chemical engineer but basically. PChem and LCT are trading in a different market segment. PChem apart from Olefins manufacturing. A big chunk of PChem revenue comes from or generate from chemicals used in acrylic ink acids, dyes, gas solvents, personal care products, fertilisers manufactoring and methanol related chemicals eg resins and ammonia. Whereas LCT specialised only in Polyolefins and PP or polypropylene eg TBA, benzene and toluene used by plastic fabricators.
2.5billion USD denominated loan is bad decision. US rate is at 5%p.a. and appreciating in value vs our MYR and the Indonesia rupiah. Zero rated Japanese YEN loan is sensible but not the USD. They are betting against USD and interest rates
Blind also knows it would not break 1.30. If unforeseen circumstances, drop below also for a few hours........mana you belajar TA??? (1.28 is 2 bids below 1.30)
12-year US$2.4 billion (about RM10.58 billion) term loan facility with The Export-Import Bank of Korea, Korea Trade Insurance Corporation and other commercial banks. It may be in Korean money lah as borrow from Korean Banks.
Never trust this kind of analysis ,report or recommendations. LC titan have incurred substantial losses for the last 5-6 Quarters. Based on their annual report. They expect a financial turnaround in their business in 2025 { when their Indonesia factory plant plan Capex expansion is completed } it's a long ...long investment commitment not a short a term buy. Anything can happen in betw 2-3 years from now
LC titan have entered into a 12 year term loan of USD 2.4 billion facility to fund the Indonesia Line project. With the USD FED rates ballooned up from 1% to current 5% and the USD exchange rate sky rocketing from 3.9 MYR to current 4.6.MYR The cost have blown up from 9.36 MYR billion to 11.04 billion MYR. It's worrying and bad for any borrowing's denominated in USD. You get hit by the exchange rate and the interest rate respectively. If the FED { Jerome Powell} continues their so called hawkish stand on inflation. Please remember do your own research before you buy or sell.
LCTITAN 1Q FY 23 loss of - MYR232 million 4Q FY 22 loss of - MYR326 million 3Q FY 22 loss of - MYR356 million 2Q FY 22 loss of - MYR 274 million Coming 2Q result expect loss betw MYR 250 million amid weakened demand & high inventories. Not a buy or sell call {Please do your research before you buy or sell}
2 Qtr result ending FY Jun 23. LC titan reported another wider nett loss of -313 million. 3 Qtr ending September is not encouraging going by the tone of the company board & management.
this Lctitan game plan is very simple. it will drop until super low valuation, then owners will privatise it then later they will relist it as super high valuations. they done it once before, and seems like they are doing it again
this share was first listed in 2005 then it slumped and was privatised in 2011 then it was relisted at super high valuations in 2017 now price is slumping, and the owners are just waiting for the right time to privatise it again for another round of super high valuation relisting
Yes. Looks like their game plan to maximise their losses prior to the Indonesia plant completion in 2025 or 2026. With 5 or 6 years of yearly high losses. Timing is right to take it private with low valuations and negative cash flow. They do it once no stopping for them to follow the second time round or in a extreme scenario. The bank will go on a auction sphree if they are unable to cough up the loans repayment. Just a pure hypothetically conjunction.
that is y sb said if you owns a listed company, you are few lucky people on the earth that can easily earn and enjoy your life..but before that you need to struggle very hard..and of course LUCK is a most important factor. BUT, if No try, definately no luck.
LCtitan in a deep sink hole. 10 year financing for app USD 2.5 billion for their Indonesia plant expansion. 2.5 x 4.6 = 11.5 billion MYR. Yearly USD interest rate at 5% pa plus currency conversion. You work out the figs
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
Introducing MY's First IPO Fund for Sophisticated Investors!
MQ Chat
New Update. Discover investment communities that resonate with your ideas
MQ Trader
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
0:17
New IPO: Carlo Rino Group Berhad, a leading fashion retailer of women’s handbags, footwear, and accessories, aims to list on the ACE Market!
MQ Trader 82 views | 15 h ago
0:17
New IPO: A homegrown air fragrance company, Vanzo Holdings Berhad aims to list on the Ace Market!
MQ Trader 211 views | 1 d ago
0:17
New IPO: Winstar Capital Berhad, a specialist in the extrusion of aluminium profiles and fabrication of aluminium ladders aims to list on the ACE Market!
MQ Trader 378 views | 2 d ago
0:17
New IPO: Topvision Eye Specialist Berhad, specializing in medical eye care services aims to list on the ACE Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Plantermen
2,242 posts
Posted by Plantermen > 2023-02-07 17:51 | Report Abuse
Myself is not a trained chemical engineer but basically. PChem and LCT are trading in a different market segment. PChem apart from Olefins manufacturing. A big chunk of PChem revenue comes from or generate from chemicals used in acrylic ink acids, dyes, gas solvents, personal care products, fertilisers manufactoring and methanol related chemicals eg resins and ammonia. Whereas LCT specialised only in Polyolefins and PP or polypropylene eg TBA, benzene and toluene used by plastic fabricators.